Alanyl-glutamine supplementation of standard treatment for C. difficile infection
Description: PROJECT NARRATIVE C. difficile infection (CDI) is the most common cause of antibiotic-induced diarrhea. Anti-C. difficile antibiotic is associated with recurrent CDI. This proposal will test whether nutritional supplementation with alanyl-glutamine, in addition to standard treatment, can reduce intestinal inflammation, recurrence, and deaths from CDI.
Funding type: research
Funder scheme: R01
Start date: 2020-07-13
End date: 2026-06-30
Investigator: CIRLE ALCANTARA WARREN (lead)
Institution: University of Virginia
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Funded outputs count: 20
Funder award ID: R01AI145322
OpenAlex ID: G5058619045
